Home / Import refusals / AEK-0788595-6/10002/1

FDA Import Refusal AEK-0788595-6/10002/1 — Sun Pharmaceutical Industries (prev. Ranbaxy)

Sun Pharmaceutical Industries (prev. Ranbaxy) — FEI 3002807977

The FDA refused shipment AEK-0788595-6/10002/1 from Sun Pharmaceutical Industries (prev. Ranbaxy) (India) on June 29, 2026. The refused product falls under Drugs and Biologics — DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT). Cited charge: 27 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 29, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61LAY41 DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT)
Charges
27

Other import refusals

  • 1FX-7764075-2/20002/1 (Tue Jun 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0744467-1/10002/1 (Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0113241-3/50002/1 (Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5786740-2/11/1 (Thu Feb 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-6360605-5/71/1 (Fri Aug 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources